San Francisco, California
London, United Kingdom
The Bioscience Network Presents:
What's in it for (23and) Me?
Date & Location
March 13, 2014
The Broad Institute
7 Cambridge Center, Cambridge,MA
Genetic Analysis for individuals is increasingly widely available. Some have classified the personal genomics era as a "Brave New World." Companies that provide these services to individuals have sprung up, and it is relatively easy to have a "genome scan" from a simple cheek swab. One of the highest-profile of these is 23andMe, likely because one of its co-founders, Anne Wojcicki, is the wife of Google co-founder Sergey Brin.
On November 22, the FDA informed 23andMe that the agency believed that the company was, "marketing the 23andMe Saliva Collection Kit and Personal Genome Service (PGS) without marketing clerance or approval in violation of the Federal Food, Drug, and Cosemtic Act (the FD&C Act)".
Has the FDA overstepped its regulatory purview? Is 23andME the tip of the iceberg? Should indivivuals have the right to their own medical information? Is the role of government to protect us from potentially harmful medical information? Myriad questions arise from this recent FDA action. Come hear a stellar panel debate the issue in a highly interactive setting!
5:30-6:30pm: Cocktails, Hors d'oeuvres and Networking
6:30-8:00pm: Panel Discussion
The Bioscience Network (TBN)
Where you are the future of life sciences
TBN is a non-profit organization providing networking and professional growth to individuals in the Bioscience industries.